- All
- News
- Publications
QUEZAD~2 Quezada, E., Knoch, K., Vasiljevic, J., Seiler, A., Pal, A., Gunasekaran, A., Münster, C., Friedland, D., Schöniger, E., Sönmez, A., Roch, P., Wegbrod, C., Ganß, K., Kipke, N., Alberti, S., Nano, R., Piemonti, L., Aust, D., Weitz, J., Distler, M., Solimena, M. (2025). Aldolase-regulated G3BP1/2+ condensates control insulin mRNA storage in beta cells. The…
Müller, A., Klena, N., Pang, S., Garcia, L. E. G., Sulaymankhil, D., Topcheva, O., Seliskar, M., Mziaut, H., Schöniger, E., Müller, A., Klena, N., Pang, S., Garcia, L. E. G., Sulaymankhil, D., Topcheva, O., Seliskar, M., Mziaut, H., Schöniger, E., Friedland, D., Kipke, N., Kretschmar, S., Münster, C., Weitz, J., Distler, M., Kurth, T., Schmidt,…
Quezada, E., Vasiljevic, J., Pal, A., Münster, C., Friedland, D., Schöniger, E., Sönmez, A., Seiler, A., Roch, P., Wegbrod, C., Ganß, K., Knoch, K., Kipke, N., Alberti, S., Nano, R., Piemonti, L., Aust, D., Weitz, J., Distler, M., & Solimena, M. (2024a). Post-transcriptional regulation of insulin mRNA storage by G3BP1/2+ condensates in beta cells. bioRxiv…
Herder, C., Roden, M., & Venteclef, N. (2024). Diabetes and pulmonary infection how hyperglycaemia shapes the immune system. Signal Transduction And Targeted Therapy, 9(1). htt Herder, C., Roden, M., & Venteclef, N. (2024). Diabetes and pulmonary infection : how hyperglycaemia shapes the immune system. Signal Transduction And Targeted Therapy, 9(1). https://doi.org/10.1038/s41392-024-01784-6
De Brachène, A. C., Alvelos, M. I., Szymczak, F., Zimath, P. L., Castela, A., De Souza, B. M., Rivada, A. R., Marín-Cañas, S., Yi, X., De Beeck, A. O., Morgan, N. G., So De Brachène, A. C., Alvelos, M. I., Szymczak, F., Zimath, P. L., Castela, A., De Souza, B. M., Rivada, A. R., Marín-Cañas,…
Julla, J., Girard, D., Diedisheim, M., Saulnier, P., Vuong, B. T., Blériot, C., Carcarino, E., De Keizer, J., Orliaguet, L., Nemazanyy, I., Potier, C., Khider, K., Tonui, D. C.,Julla, J., Girard, D., Diedisheim, M., Saulnier, P., Vuong, B. T., Blériot, C., Carcarino, E., De Keizer, J., Orliaguet, L., Nemazanyy, I., Potier, C., Khider, K., Tonui,…
INTERCEPT-T2D partners head to EASD 2025 in Vienna, where Yanni Morgenroth will give an oral presentation. More to come.
The consortium gathered in Stockholm on 25–26 February 2025 to reflect on 2024’s achievements and exchange insights from the past year
INTERCEPT-T2D members convened at the 60th Annual EASD Congress in Madrid to engage with experts on inflammation and type 2 diabetes and strengthen their collaboration.
On March 20, 2024, at the Annual Congress of the Société Francophone du Diabète, two presentations highlighted the progress of the INTERCEPT-T2D project (CHUL and AP-HP)
First Patient Enrolled in a Phase 2 Study in Patients with Type 2 Diabetes with Olatec’s NLRP3 Inhibitor, Dapansutrile
*Article in French* Read an article made by our partner “the Federation Française des diabétiques” about the project’s coordinator Nicolas Venteclef and the project INTERCEPT-T2D in their newsletter
The consortium met again in Basel on the 6&7 of December to review the progress and accomplishments of the year 2023.
Listen to Dr. Marc Donath, Head of Clinic for Endocrinology, Diabetes & Metabolism, Uni Spital Basel speaking about INTERCEPT-T2D
The coordinator and its lab were present at the annual meeting of the diabetic society..
The project kick-off has taken place on the 11th and 12th of January in Paris at Necker Institute.
